The U.S. Supreme Court on Monday requested the opinion of the Solicitor General in a legal dispute involving Bayer’s ( ...

Patients with antiphospholipid antibodies (aPL) are at increased risk for arterial or venous thrombosis. There is, however, significant heterogeneity among patients according to clinical and ...

I am a 64-year-old man who has been having periodic shortness of breath for the past six months or so. This happens mostly ...

The data was presented at the Cancer Research UK Prevention Conference earlier this week, supported by the charity and Stand Up To Cancer funding. It noted that low dose aspirin, ...

Inclusion criteria: Adults (18 years old or older) taking antiplatelet drugs for at least 2 weeks; scheduled for elective or emergency neurosurgery under general anaesthesia (craniotomy, spinal cord ...

Although the results of a number of clinical studies indicate that aspirin may function as a broad spectrum cancer prevention agent, the results have been mixed, due to different study designs ...

Current guidelines recommend routine aspirin thromboprophylaxis after each stage of palliation for children with single ventricle heart disease. 1 In the only randomized trial to evaluate efficacy of ...

The daily use of low-dose aspirin against heart disease may have taken another knock. New research shows that the practice may not provide the added benefit of reduced heart attack risk to Black ...

If you are buying name brands like Advil, Tylenol, Bayer Aspirin, Prilosec, Zyrtec, Claritin and Sudafed, you are wasting your money. You are paying up to three times as much as that medication ...

Objective: Since 1997, the American Diabetes Association has recommended that aspirin therapy be considered for adults with diabetes who have cardiovascular disease (CVD) or CVD risk factors. We ...

High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects the long-term course.

MDIs, primarily as SABA or ICS, accounted for over half of inhalers dispensed to US older adults. Most insurance plans excluded sustainable alternatives for SABA/ICS. When covered, additional approval ...